Exact Mass: 565.3152

A polyketide that is 5-amino-5-deoxy-3,4,5,6-tetrahydrouridine in which one of the hydrogens of the amino group is substituted by a (1E,3E)-1-[(1R,1R,1R,1R,2S,2R,2R,2S)-2-{(E)-2-[(1R,2R)-2-methylcyclopropyl]ethenyl}[1,1:2,1:2,1-quater(cyclopropan)]-2-yl]-5-oxopenta-1,3-dien-5-yl group. It is a metabolite isolated from the bacterium, Streptoverticillium fervens and targets the catalytic subunit of the fungal UDP-glycosyltransferase, the first step in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. It exhibits broad spectrum antifungal activity against several pathogenic fungi including Mucorales.

7-O-acetyl-19,20-epoxycytochalasin C

7-O-acetyl-19,20-epoxycytochalasin D

Fibrinogen-Binding Peptide

C25H39N7O8 (565.286)

Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin[1].

For-Met-Leu-Phe-Lys-OH

C27H43N5O6S (565.2934)

N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively[1].

Cinaciguat

C36H39NO5 (565.2828)

C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-2-Amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]methylamino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetic acid

C30H39N5O6 (565.29)

Joro spider toxin

ST 28:4;O4;Tau

C30H47NO7S (565.3073)

ST 29:3;O3;Tau

C31H51NO6S (565.3437)

JNJ-31020028

C34H36FN5O2 (565.2853)

JNJ-31020028 is a selective and brain penetrant antagonist of neuropeptide Y Y2 receptor with pIC50 values of 8.07 and 8.22 for human and rat Y2 receptor, respectively. JNJ-31020028 can be used for the research of nervous disease[1].

MRTX-1257

C33H39N7O2 (565.3165)

MRTX-1257 is a selective, irreversible, covalent and orally active KRAS G12C inhibitor, with an IC50 of 900 pM for KRAS dependent ERK phosphorylation in H358 cells[1].

n-(5-{[3-({4-[(3-aminopropyl)amino]butyl}amino)-1-hydroxypropylidene]amino}pentyl)-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C27H47N7O6 (565.3588)

(2e,4e)-n-{[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1'r,2s)-2'-[(1'r,2r,2's)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1'r,2s)-2'-[(1'r,2r,2's)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

7'-(3,3-dimethyloxirane-2-carbonyl)-1-formyl-2'-hydroxy-1,6-dimethyl-3a-(methylamino)-4,6,7,8,9,9a,10,10a-octahydro-3h-spiro[cyclopenta[b]quinolizine-2,3'-indol]-8-yl butanoate

2-{[2-amino-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-5-(2-{[2-amino-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-n,3-dihydroxybutanamido)pentanoic acid

C21H39N7O11 (565.2707)

(2s)-2-(4-{2-[(1r,2e,4ar,4bs,8as,10as)-4b,8,8,10a-tetramethyl-2-[(sulfooxy)methylidene]-decahydrophenanthren-1-yl]ethyl}-2-oxo-5h-pyrrol-1-yl)-3-methylbutanoic acid

C30H47NO7S (565.3073)

(3s,6s,9s,16r,21as)-3-ethyl-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(2-methylpropyl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

(3s,6s,9s,16r,21as)-3-ethyl-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(2-methylpropyl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

3-({3-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-5-(n-methylcarbamimidamido)pentylidene}amino)-6-[2-hydroxy-5-(hydroxymethyl)-4-iminopyrimidin-1-yl]-3,6-dihydro-2h-pyran-2-carboxylic acid

3-({3-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-5-(n-methylcarbamimidamido)pentylidene}amino)-6-[2-hydroxy-5-(hydroxymethyl)-4-iminopyrimidin-1-yl]-3,6-dihydro-2h-pyran-2-carboxylic acid

C24H39N9O7 (565.2972)

(2e,4e)-n-{[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1s,1's,2r,2's)-2'-[(1s,1's,2s,2'r)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1s,1's,2r,2's)-2'-[(1s,1's,2s,2'r)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

5,11-dihydroxy-7,9,14-trimethyl-13-methylidene-6-(2-phenylethyl)-15-(4,6,6-trimethylhepta-2,4-dien-2-yl)-1-oxa-4,7,10-triazacyclopentadeca-4,10-diene-2,8-dione

C33H47N3O5 (565.3516)

(1r,2s,3s,5s,6r,8s,10e,12r,13s,16r,17s)-13-(acetyloxy)-17-benzyl-6,19-dihydroxy-6,8,14,15-tetramethyl-7-oxo-4-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0³,⁵]nonadeca-10,14,18-trien-2-yl acetate

(2e,4e)-n-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1r,1'r,2r,2's)-2'-[(1r,1's,2r,2'r)-2'-[(1z)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1r,1'r,2r,2's)-2'-[(1r,1's,2r,2'r)-2'-[(1z)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

[(2s,4s,6s)-6-[(1e,3e)-5-[(2s,3s,5r,6r)-5-{[(2z,4s)-4-(acetyloxy)-1-hydroxypent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl]-3-methylpenta-1,3-dien-1-yl]-4-(ethoxymethyl)-4-hydroxyoxan-2-yl]acetic acid

[(2s,4s,6s)-6-[(1e,3e)-5-[(2s,3s,5r,6r)-5-{[(2z,4s)-4-(acetyloxy)-1-hydroxypent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl]-3-methylpenta-1,3-dien-1-yl]-4-(ethoxymethyl)-4-hydroxyoxan-2-yl]acetic acid

C30H47NO9 (565.3251)

(6s,9s,14r,15r)-5,11-dihydroxy-7,9,14-trimethyl-13-methylidene-6-(2-phenylethyl)-15-[(2e,4e)-4,6,6-trimethylhepta-2,4-dien-2-yl]-1-oxa-4,7,10-triazacyclopentadeca-4,10-diene-2,8-dione

C33H47N3O5 (565.3516)

6,15-dihydroxy-11-isopropyl-4,5,10,13,14-pentamethyl-2-(prop-2-en-1-yl)-8-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-6,15-diene-3,9,12,19-tetrone

(2s)-2-{[(2r)-2-amino-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-5-[(2r,3r)-2-{[(2r)-2-amino-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-n,3-dihydroxybutanamido]pentanoic acid

C21H39N7O11 (565.2707)

repromicin

C31H51NO8 (565.3614)

(2r,3r,6s)-3-{[(3r)-3-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-5-(n-methylcarbamimidamido)pentylidene]amino}-6-[2-hydroxy-5-(hydroxymethyl)-4-iminopyrimidin-1-yl]-3,6-dihydro-2h-pyran-2-carboxylic acid

(2r,3r,6s)-3-{[(3r)-3-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-5-(n-methylcarbamimidamido)pentylidene]amino}-6-[2-hydroxy-5-(hydroxymethyl)-4-iminopyrimidin-1-yl]-3,6-dihydro-2h-pyran-2-carboxylic acid

C24H39N9O7 (565.2972)

(1r,2s,3s,5s,6r,8s,10e,12r,13s,15s,16r,17s)-13-(acetyloxy)-17-benzyl-6,19-dihydroxy-6,8,15-trimethyl-14-methylidene-7-oxo-4-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0³,⁵]nonadeca-10,18-dien-2-yl acetate

(1r,2s,3s,5s,6r,8s,10e,12r,13s,15s,16r,17s)-13-(acetyloxy)-17-benzyl-6,19-dihydroxy-6,8,15-trimethyl-14-methylidene-7-oxo-4-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0³,⁵]nonadeca-10,18-dien-2-yl acetate

(3s,6'r,7'r,8'as)-6'-ethenyl-7'-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-7-[(2r)-1-methylpyrrolidin-2-yl]-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizine]-2,6-diol

C35H43N5O2 (565.3417)

2-(6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-4-hydroxy-5,9,13,15-tetramethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl)acetaldehyde

C31H51NO8 (565.3614)

(3s,6s,9s,16r,21as)-1,4,10-trihydroxy-3,6-diisopropyl-8,9-dimethyl-16-(2-methylpropyl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-7,14,17-trione

(1r,2r,3as,6s,8r,9as,10ar)-7'-[(2s)-3,3-dimethyloxirane-2-carbonyl]-1-formyl-2'-hydroxy-1,6-dimethyl-3a-(methylamino)-4,6,7,8,9,9a,10,10a-octahydro-3h-spiro[cyclopenta[b]quinolizine-2,3'-indol]-8-yl butanoate

(1r,2r,3as,6s,8r,9as,10ar)-7'-[(2s)-3,3-dimethyloxirane-2-carbonyl]-1-formyl-2'-hydroxy-1,6-dimethyl-3a-(methylamino)-4,6,7,8,9,9a,10,10a-octahydro-3h-spiro[cyclopenta[b]quinolizine-2,3'-indol]-8-yl butanoate

(2s)-n-(5-{[3-({4-[(3-aminopropyl)amino]butyl}amino)-1-hydroxypropylidene]amino}pentyl)-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C27H47N7O6 (565.3588)

(2r,8s,11s,14s)-6,15-dihydroxy-11-isopropyl-4,5,10,13,14-pentamethyl-2-(prop-2-en-1-yl)-8-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-6,15-diene-3,9,12,19-tetrone